Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06468800

Feasibility and Added Value of the TRACMOTION Device for ESD

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Erasmus Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A single center non-randomized prospective clinical study, to evaluate the feasibility and added value of the CE-certified Tracmotion device in patients scheduled consecutively for ESD in the upper and lower gastrointestinal tract. After ESD, the endoscopists' opinion will be evaluated with a short questionnaire on experience with the Tracmotion device. The pathology report will be checked for radicality and microscopic damage of the removed lesion.

Detailed description

Objective: The purpose of this study is to establish feasibility of the Tracmotion device for ESD and to define its added value during ESD in both upper and lower GI procedures, both in antegrade and in retroflex positions. Study design: Single center prospective observational non-randomized clinical study. Study population: A total of 20 consecutive cases scheduled for ESD will be included. Sample size calculation does not apply for this type of study. Patients already scheduled for ESD will undergo an ESD procedure as planned with the aid of the Tracmotion device. It is anticipated that the Tracmotion will provide superior traction and counter traction compared to off-label tools. Intervention: Patients already scheduled for ESD will undergo an ESD procedure with the aid of the Tracmotion device. Main study parameters/endpoints: Feasibility: procedure time, dissection speed, lesional damage (tearing or grasping injury to the mucosa on macroscopy and pathological review) Added value: subjective evaluation of the Tracmotion device by the performing endoscopist (contentment of use of Tracmotion, difference in procedure time, stability of, control of and accessibility to the lesion).

Conditions

Interventions

TypeNameDescription
DEVICETRACMOTIONPatients already scheduled for ESD will undergo an ESD procedure with the aid of the Tracmotion device

Timeline

Start date
2024-10-01
Primary completion
2025-02-01
Completion
2025-03-01
First posted
2024-06-21
Last updated
2024-08-28

Source: ClinicalTrials.gov record NCT06468800. Inclusion in this directory is not an endorsement.